Effect of Polyphenol-rich Cocoa Products on Cognitive Function
Launched by QUEEN MARGARET UNIVERSITY · Dec 14, 2016
Trial Information
Current as of October 19, 2025
Completed
Keywords
ClinConnect Summary
Healthy cognitive ageing is an important aspect of the ageing process as it involves larger numbers of people compared to those who have already been diagnosed with conditions on the dementia spectrum (Deary et al, 2009). Hence, an active effort looking at potential lifestyle factor modification interventions to help maintain cognitive well-being are warranted.
With an ageing population, the prevalence of cognitive syndromes such as Alzheimer's disease and Parkinson's disease increases (Vauzour, 2012). Nutritional interventions can play a role in successful ageing by helping to delay the o...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Males \& Females aged 50-60years of age with normal or corrected to normal vision
- • BMI cut off points of ≥18.5 to ≤29.9 kg/m2
- • Waist circumference smaller than 102cm for males \& smaller than 88cm for women
- • Blood pressure of ≥ 90 over 60 and ≤ 120 over 80
- • MoCA test score ≥ 26
- Exclusion Criteria:
- • Allergies to cocoa or any other ingredients commonly found in cocoa confectionary eg: milk, nuts, soya
- • Smoker
- • Women who are new or expecting mothers, maybe or are currently pregnant and/or breastfeeding
- • Taking medications for chronic conditions including (but not limited to) diabetes, heart disease, hypertension
- • No previous history of stroke, brain trauma and other head-related injuries
- • No diagnosis of depression and/or anxiety
- • No previous cancer diagnosis
- • Taking antibiotics
- • Taking steroids and non-steroidal anti-inflammatory drugs (NSAIDS)
- • Women on Hormone Replacement Therapy (HRT)
- • Taking medication that can cause drowsiness or affect cognitive functioning
- • Taking polyphenol supplements including (but not limited to) green tea extract, acai berry extract
- • Taking soy/a supplements
- • History of alcohol misuse
- • Fear of needles and/or fainting when blood is taken
About Queen Margaret University
Queen Margaret University (QMU) is a renowned institution dedicated to advancing health and social care through innovative research and academic excellence. With a strong emphasis on interdisciplinary collaboration, QMU engages in clinical trials that aim to enhance patient outcomes and inform evidence-based practices. The university’s commitment to addressing real-world health challenges is reflected in its partnerships with healthcare providers and stakeholders, ensuring that research findings translate effectively into practice. Through its robust ethical standards and focus on participant welfare, QMU is poised to contribute significantly to the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edinburgh, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials